DoH, Takeda Pharmaceuticals ink strategic partnership to advance rare diseases, oncology research
Jun 05, 2024
Abu Dhabi [UAE], June 5: The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding (MoU) with Takeda Pharmaceuticals, a values-based biopharmaceutical company with a Japanese Heritage, during the BIO International Convention 2024 in San Diego, USA. The strategic cooperation aims to establish a framework of collaboration to enhance research endeavours in rare diseases and oncology.
Read More...
